Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 11, 2013Journal of Antimicrobial ChemotherapyOpen Access

Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome

View Full Paper
Ask AI
Bookmark
Share

Authors

TKTheodoros KelesidisThe University of Texas Southwestern Medical CenterRTRyan TewheyTufts UniversityRHRomney M. HumphriesVanderbilt University Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kelesidis et al. (2013) studied this question.

synapsesocial.com/papers/6a77df00c5ab23c76cecfa4chttps://doi.org/10.1093/jac/dkt117
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Intradialytic Administration of Daptomycin in End Stage Renal Disease Patients on Hemodialysis2009 · 43 citations
  2. 2Daptomycin Nonsusceptible Enterococci: An Emerging Challenge for Clinicians2010 · 150 citations
  3. 3Genetic Basis for Daptomycin Resistance in Enterococci2011 · 200 citations
  4. 4Case-Control Study Comparing <i>De Novo</i> and Daptomycin-Exposed Daptomycin-Nonsusceptible Enterococcus Infections2012 · 21 citations
  5. 5Genotypic and Phenotypic Evaluation of the Evolution of High-Level Daptomycin Nonsusceptibility in Vancomycin-Resistant Enterococcus faecium2012 · 69 citations